Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients

V. Kemény, Sándor Molnár, Mónika Andrejkovics, Attila Makai, L. Csiba

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A double-blind, prospective, randomized, placebo-controlled clinical trial was carried out to test the acute and long-term hemodynamical and beneficial cognitive effects of the vasoactive agent vinpocetine on patients suffering from multiple cerebral infarcts by means of functional transcranial Doppler examinations and by neuropsychological tests. Twenty-six patients (17 men, 9 women) with multiple cerebral infarctions, aged between 50 and 83 years (mean age ± SD = 63.4 ± 9.39 years) were examined, 14 of whom received vinpocetine and 12 placebo. The functional transcranial Doppler included breath-holding tests, finger movement, word fluency, and picture-discrimination tasks. Twenty-five patients were assessed by neuropsychological battery. No serious side effect was found in the vinpocetine group. The flow velocities were significantly lower in the acute phase after breath holding in the vinpocetine group than in the placebo group. Three months later, the vinpocetine patients did not show any significant worsening in digit span backward test, while the placebo group did. No other significant differences in the neuropsychological test could be detected between the treatment and the placebo groups. Langer lasting and higher dosage of vinpocetine therapy is suggested to prove its potential effect.

Original languageEnglish
Pages (from-to)1048-1054
Number of pages7
JournalJournal of Clinical Pharmacology
Volume45
Issue number9
DOIs
Publication statusPublished - Sep 2005

Fingerprint

vinpocetine
Hemodynamics
Placebos
Breath Holding
Neuropsychological Tests
Breath Tests
Cerebral Infarction
Fingers
Randomized Controlled Trials

Keywords

  • Cerebral infarctions
  • Cognitive impairment
  • Functional TCD
  • Neuropsychology
  • Vinpocetine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients. / Kemény, V.; Molnár, Sándor; Andrejkovics, Mónika; Makai, Attila; Csiba, L.

In: Journal of Clinical Pharmacology, Vol. 45, No. 9, 09.2005, p. 1048-1054.

Research output: Contribution to journalArticle

@article{4782a49d6e3349428467dfa49d0d8306,
title = "Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients",
abstract = "A double-blind, prospective, randomized, placebo-controlled clinical trial was carried out to test the acute and long-term hemodynamical and beneficial cognitive effects of the vasoactive agent vinpocetine on patients suffering from multiple cerebral infarcts by means of functional transcranial Doppler examinations and by neuropsychological tests. Twenty-six patients (17 men, 9 women) with multiple cerebral infarctions, aged between 50 and 83 years (mean age ± SD = 63.4 ± 9.39 years) were examined, 14 of whom received vinpocetine and 12 placebo. The functional transcranial Doppler included breath-holding tests, finger movement, word fluency, and picture-discrimination tasks. Twenty-five patients were assessed by neuropsychological battery. No serious side effect was found in the vinpocetine group. The flow velocities were significantly lower in the acute phase after breath holding in the vinpocetine group than in the placebo group. Three months later, the vinpocetine patients did not show any significant worsening in digit span backward test, while the placebo group did. No other significant differences in the neuropsychological test could be detected between the treatment and the placebo groups. Langer lasting and higher dosage of vinpocetine therapy is suggested to prove its potential effect.",
keywords = "Cerebral infarctions, Cognitive impairment, Functional TCD, Neuropsychology, Vinpocetine",
author = "V. Kem{\'e}ny and S{\'a}ndor Moln{\'a}r and M{\'o}nika Andrejkovics and Attila Makai and L. Csiba",
year = "2005",
month = "9",
doi = "10.1177/0091270005279363",
language = "English",
volume = "45",
pages = "1048--1054",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients

AU - Kemény, V.

AU - Molnár, Sándor

AU - Andrejkovics, Mónika

AU - Makai, Attila

AU - Csiba, L.

PY - 2005/9

Y1 - 2005/9

N2 - A double-blind, prospective, randomized, placebo-controlled clinical trial was carried out to test the acute and long-term hemodynamical and beneficial cognitive effects of the vasoactive agent vinpocetine on patients suffering from multiple cerebral infarcts by means of functional transcranial Doppler examinations and by neuropsychological tests. Twenty-six patients (17 men, 9 women) with multiple cerebral infarctions, aged between 50 and 83 years (mean age ± SD = 63.4 ± 9.39 years) were examined, 14 of whom received vinpocetine and 12 placebo. The functional transcranial Doppler included breath-holding tests, finger movement, word fluency, and picture-discrimination tasks. Twenty-five patients were assessed by neuropsychological battery. No serious side effect was found in the vinpocetine group. The flow velocities were significantly lower in the acute phase after breath holding in the vinpocetine group than in the placebo group. Three months later, the vinpocetine patients did not show any significant worsening in digit span backward test, while the placebo group did. No other significant differences in the neuropsychological test could be detected between the treatment and the placebo groups. Langer lasting and higher dosage of vinpocetine therapy is suggested to prove its potential effect.

AB - A double-blind, prospective, randomized, placebo-controlled clinical trial was carried out to test the acute and long-term hemodynamical and beneficial cognitive effects of the vasoactive agent vinpocetine on patients suffering from multiple cerebral infarcts by means of functional transcranial Doppler examinations and by neuropsychological tests. Twenty-six patients (17 men, 9 women) with multiple cerebral infarctions, aged between 50 and 83 years (mean age ± SD = 63.4 ± 9.39 years) were examined, 14 of whom received vinpocetine and 12 placebo. The functional transcranial Doppler included breath-holding tests, finger movement, word fluency, and picture-discrimination tasks. Twenty-five patients were assessed by neuropsychological battery. No serious side effect was found in the vinpocetine group. The flow velocities were significantly lower in the acute phase after breath holding in the vinpocetine group than in the placebo group. Three months later, the vinpocetine patients did not show any significant worsening in digit span backward test, while the placebo group did. No other significant differences in the neuropsychological test could be detected between the treatment and the placebo groups. Langer lasting and higher dosage of vinpocetine therapy is suggested to prove its potential effect.

KW - Cerebral infarctions

KW - Cognitive impairment

KW - Functional TCD

KW - Neuropsychology

KW - Vinpocetine

UR - http://www.scopus.com/inward/record.url?scp=23944516257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944516257&partnerID=8YFLogxK

U2 - 10.1177/0091270005279363

DO - 10.1177/0091270005279363

M3 - Article

VL - 45

SP - 1048

EP - 1054

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 9

ER -